Soy isoflavone may inhibit common gastrointestinal illness in infants

The soy isoflavone genistin--at concentrations present in soy infant formula-- may reduce a baby’s susceptibility to rotavirus infections by as much as 74 percent, according to a University of Illinois study published in September’s Journal of Nutrition.

“Rotavirus is the primary cause of diarrhea in infants, affecting virtually all children before age five. In the United States, it mainly leads to dehydration, doctor’s visits, and parents missing work to care for sick children. In developing countries, though, rotavirus causes approximately 611,000 deaths each year,” said Sharon Donovan, the Melissa M. Noel Professor of Nutrition at the U of I.

Although rotavirus vaccines have recently become available, they are expensive and cannot be given to some infants, she said.

“It’s exciting to think that the isoflavones in soy formula could be a cost-effective nutritional approach to decreasing the incidence and severity of rotavirus infections, especially among children in developing countries who are most at risk,” said the scientist of her work with doctoral candidate Aline Andres, who conducted the experiments.

In the study, cells in culture were exposed to rotavirus in the absence or presence of soy isoflavones, biologically active compounds in soy that are thought to have health benefits. Soy contains a number of different forms of isoflavones, and all were tested individually and as the complete mixture present in infant formula.

“Genistin and the mixture significantly reduced rotavirus infectivity by 33 to 74 percent,” she said. “But when genistin was taken out of the mixture, anti-rotavirus activity was lost, suggesting that it is the active component in reducing infectivity.”

Donovan focused her investigation on the isoflavone concentrations present in soy formula. That was the concentration at which rotavirus inhibition began to occur and then leveled off, indicating that there’s an effective range, and beyond that, there is no additional inhibition or toxicity.

“We then exposed the cells to different concentrations of rotavirus. If an infant had a severe infection or was exposed to a lot of rotavirus, we wondered if the isoflavones would still be as effective,” she said.

The inhibition held up across a 16-fold range of rotavirus exposure. “Even at the highest concentration of rotavirus particles, genistin or the mix of isoflavones inhibited infectivity,” said Donovan.

Genistin appeared to diminish infectivity by inhibiting binding of the virus to tissue-culture cells, she said.

Donovan’s laboratory soon plans to begin studies with neonatal piglets, an excellent model for studying rotavirus infection and the nutritional effects of various components on the intestine.

“We’ll be interested to see if we have the same results when we work with young animals,” she said.

Source: University of Illinois at Urbana-Champaign

Related stories:

The way to a virus' 'heart' is through its enzymes
The arrival of bluetongue virus (BTV) in the UK last year posed a major threat to the economy and the increasing temperatures of our changing climate mean it is here to stay. If we are to fight this disease, which has had a major impact on farming already, we must discover how it works. A review published in the August issue of the Journal of General Virology outlines our current understanding of the "heart" of the virus, which may help us to develop antiviral therapies to treat many human pathogens.
Integrins as receptors give insight into rotavirus and diarrhea
Eleven years ago, Dr. Mary Estes of Baylor College of Medicine and her colleagues discovered the first viral enterotoxin, rotavirus NSP4, a toxic protein that affects the intestines, causing diarrhea.
Tool creates personalized catch-up immunization schedules for missed childhood vaccinations
A new downloadable software tool will help pediatricians, parents and other health care professionals determine how to adjust complex childhood immunization schedules when one or more vaccine doses aren’t received at the proper time.
China's biotech industry: An Asian dragon is growing
Backed by a government intent on promoting innovation and fuelled by the “brain gain” of talented scientists and entrepreneurs returning from abroad, China’s health biotech industry only needs a more favourable investment climate to emerge as a global force in the production of therapies and medicines – both new and low-cost generics – experts say in a new study.
Mucosal-surface immune function discoveries could boost vaccine research
In a finding that could have important implications for HIV vaccine research, new research at Weill Cornell Medical College illuminates the ways in which the body prevents its mucosal surfaces from being overwhelmed by bacteria.
Researchers Endorse Global Early Warning System to Prevent Pandemics
Could the HIV pandemic have been prevented? Nathan Wolfe, professor of epidemiology at the UCLA School of Public Health, says yes, and he's working to prevent the next one.
Students Devise Oral Quick-Dissolve Strips for Rotavirus Vaccine
A thin strip that dissolves in the mouth like a popular breath-freshener could someday provide life-saving rotavirus vaccine to infants in impoverished areas. The innovative drug-delivery system was developed by Johns Hopkins undergraduate biomedical engineering students.
Rotavirus can spread beyond the intestine
A new study in PLoS Medicine has shown that children who have rotavirus, a very common cause of diarrhea in children, and who have antigens (protein fragments from the surface of the virus) in their blood, also have infectious virus in their blood.

News discussion:

Medicine & Health news